{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:42:33Z","timestamp":1743975753087,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1124\/jpet.105.091066","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T19:49:17Z","timestamp":1132170557000},"page":"996-1004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["BP-1107 [{2-[4-(2,4-Dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: A Novel Synthetic Thiazolidinedione That Inhibits Epidermal Hyperplasia in Psoriatic Skin-Severe-Combined Immunodeficient Mouse Transplants after Topical Application"],"prefix":"10.1016","volume":"315","author":[{"given":"Narasimharao","family":"Bhagavathula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalakar C.","family":"Nerusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendranath","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles N.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Chittiboyina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrihar A.","family":"Pershadsingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore W.","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Varani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.091066_bib1","doi-asserted-by":"crossref","unstructured":"Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, and Salzsieder E (2003) Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells. Biochem Biophys Res Commun 304: 378\u2013384.","DOI":"10.1016\/S0006-291X(03)00590-4"},{"key":"10.1124\/jpet.105.091066_bib2","doi-asserted-by":"crossref","unstructured":"Austin LM, Ozawa M, Kikuchi T, Walters IB, and Krueger JG (1999) The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2 and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Investig Dermatol 113: 752\u2013759.","DOI":"10.1046\/j.1523-1747.1999.00749.x"},{"key":"10.1124\/jpet.105.091066_bib3","doi-asserted-by":"crossref","unstructured":"Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L, Kumar S, Xu ZH, Hinton P, Tsurushita N, et al. (2005) Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. Am J Pathol 166: 1009\u20131016.","DOI":"10.1016\/S0002-9440(10)62322-X"},{"key":"10.1124\/jpet.105.091066_bib4","doi-asserted-by":"crossref","unstructured":"Bhagavathula N, Nerusu KC, Lal A, Ellis CN, Chittiboyina A, Avery MA, Ho CI, Benson SC, Pershadsingh HA, Kurtz TW, et al. (2004) Rosiglitazone inhibits proliferation, motility and matrix metalloproteinase production in keratinocytes. J Investig Dermatol 122: 130\u2013139.","DOI":"10.1046\/j.0022-202X.2003.22111.x"},{"key":"10.1124\/jpet.105.091066_bib5","doi-asserted-by":"crossref","unstructured":"Brennan M, Bhatti H, Nerusu KC, Bhagavathula N, Kang S, Fisher GJ, Varani J, and Voorhees JJ (2003) Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem Photobiol 78: 43\u201348.","DOI":"10.1562\/0031-8655(2003)078<0043:MMITMC>2.0.CO;2"},{"key":"10.1124\/jpet.105.091066_bib6","doi-asserted-by":"crossref","unstructured":"Cook PW, Brown JR, Cornell KA, and Pittelkow MR (2004) Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp Dermatol 13: 347\u2013356.","DOI":"10.1111\/j.0906-6705.2004.00183.x"},{"key":"10.1124\/jpet.105.091066_bib7","doi-asserted-by":"crossref","unstructured":"Cook PW, Piepkorn M, Clegg CH, Plowman GD, DeMay JM, Brown JR, and Pittelkow MR (1997) Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Investig 100: 2286\u20132294.","DOI":"10.1172\/JCI119766"},{"key":"10.1124\/jpet.105.091066_bib8","unstructured":"Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ Jr, and Shipley GD (1992) Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res 52: 3224\u20133227."},{"key":"10.1124\/jpet.105.091066_bib9","doi-asserted-by":"crossref","unstructured":"Culver DA, Barna BP, Raychaudhuri B, Bonfield TL, Abraham S, Malur A, Farver CF, Kavuru MS, and Thomassen MJ (2004) Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 30: 1\u20135.","DOI":"10.1165\/rcmb.2003-0304RC"},{"key":"10.1124\/jpet.105.091066_bib10","doi-asserted-by":"crossref","unstructured":"Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, Ellingsworth L, Derynck R, and Voorhees JJ (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (Wash DC) 243: 811\u2013814.","DOI":"10.1126\/science.2916128"},{"key":"10.1124\/jpet.105.091066_bib11","doi-asserted-by":"crossref","unstructured":"Ellis CN, Varani J, Fisher GJ, Zeigler ME, Pershadsingh HA, Benson SC, Chi Y, and Kurtz TW (2000) Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. Arch Dermatol 136: 609\u2013616.","DOI":"10.1001\/archderm.136.5.609"},{"key":"10.1124\/jpet.105.091066_bib12","doi-asserted-by":"crossref","unstructured":"Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang Z, Li X, Wan Y, Kang S, and Voorhees JJ (1998) Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Investig 101: 1432\u20131440.","DOI":"10.1172\/JCI2153"},{"key":"10.1124\/jpet.105.091066_bib13","doi-asserted-by":"crossref","unstructured":"Gibbs DF, Warner RL, Weiss SJ, Johnson KJ, and Varani J (1999) Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am J Respir Cell Mol Biol 20: 1136\u20131144.","DOI":"10.1165\/ajrcmb.20.6.3483"},{"key":"10.1124\/jpet.105.091066_bib14","doi-asserted-by":"crossref","unstructured":"Gilhar A, David M, Ullmann Y, Berkutski T, and Kalish RS (1997) T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J Investig Dermatol 109: 283\u2013288.","DOI":"10.1111\/1523-1747.ep12335758"},{"key":"10.1124\/jpet.105.091066_bib15","doi-asserted-by":"crossref","unstructured":"Gottlieb AB, Chang CK, Posnett DN, Fanelli B, and Tam JP (1988) Detection of transforming growth factor alpha in normal, malignant and hyperproliferative human keratinocytes. J Exp Med 167: 670\u2013675.","DOI":"10.1084\/jem.167.2.670"},{"key":"10.1124\/jpet.105.091066_bib16","doi-asserted-by":"crossref","unstructured":"Hasegawa H, Takano H, Zou Y, Qin Y, Hizukuri K, Odaka K, Toyozaki T, and Komuro I (2005) Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1\/Th2 balance. J Mol Cell Cardiol 38: 257\u2013265.","DOI":"10.1016\/j.yjmcc.2004.11.010"},{"key":"10.1124\/jpet.105.091066_bib17","doi-asserted-by":"crossref","unstructured":"Komuves LG, Hanley K, Jiang Y, Elias PM, Williams ML, and Feingold KR (1998) Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Investig Dermatol 111: 429\u2013433.","DOI":"10.1046\/j.1523-1747.1998.00296.x"},{"key":"10.1124\/jpet.105.091066_bib18","unstructured":"Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, and Koeffler HP (1998) Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58: 3344\u20133352."},{"key":"10.1124\/jpet.105.091066_bib19","doi-asserted-by":"crossref","unstructured":"Lebovitz HE (2002) Differentiating members of the thiazolidinedione class: a focus on safety. Diabetes Metab Res Rev 18 (Suppl 2): S23\u2013S29.","DOI":"10.1002\/dmrr.252"},{"key":"10.1124\/jpet.105.091066_bib20","doi-asserted-by":"crossref","unstructured":"Mao-Qiang M, Fowler AJ, Schmuth M, Lau P, Chang S, Brown BE, Moser AH, Michalik L, Desvergne B, Wahli W, et al. (2004) Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J Investig Dermatol 123: 305\u2013312.","DOI":"10.1111\/j.0022-202X.2004.23235.x"},{"key":"10.1124\/jpet.105.091066_bib21","doi-asserted-by":"crossref","unstructured":"Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S, and Spiegelman BM (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1: 465\u2013470.","DOI":"10.1016\/S1097-2765(00)80047-7"},{"key":"10.1124\/jpet.105.091066_bib22","doi-asserted-by":"crossref","unstructured":"Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127: 871\u2013884.","DOI":"10.1001\/archderm.127.6.871"},{"key":"10.1124\/jpet.105.091066_bib23","unstructured":"Nickoloff BJ, Kunkel SL, Burdick M, and Strieter RM (1995) Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model. Am J Pathol 146: 580\u2013588."},{"key":"10.1124\/jpet.105.091066_bib24","doi-asserted-by":"crossref","unstructured":"Pershadsingh HA, Sproul JA, Benjamin E, Finnegan J, and Amin NM (1998) Treatment of psoriasis with troglitazone therapy. Arch Dermatol 134: 1304\u20131305.","DOI":"10.1001\/archderm.134.10.1304"},{"key":"10.1124\/jpet.105.091066_bib25","doi-asserted-by":"crossref","unstructured":"Piepkorn M, Pittelkow MR, and Cook PW (1998) Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J Investig Dermatol 111: 715\u2013721.","DOI":"10.1046\/j.1523-1747.1998.00390.x"},{"key":"10.1124\/jpet.105.091066_bib26","doi-asserted-by":"crossref","unstructured":"Piepkorn M, Predd H, Underwood R, and Cook P (2003) Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res 295: 93\u2013101.","DOI":"10.1007\/s00403-003-0391-x"},{"key":"10.1124\/jpet.105.091066_bib27","doi-asserted-by":"crossref","unstructured":"Rivier M, Castiel I, Safonova I, Ailhaud G, and Michel S (2000) Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. J Investig Dermatol 114: 681\u2013687.","DOI":"10.1046\/j.1523-1747.2000.00939.x"},{"key":"10.1124\/jpet.105.091066_bib28","doi-asserted-by":"crossref","unstructured":"Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, and Michel S (1998) Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Investig Dermatol 111: 1116\u20131121.","DOI":"10.1046\/j.1523-1747.1998.00439.x"},{"key":"10.1124\/jpet.105.091066_bib29","doi-asserted-by":"crossref","unstructured":"Robertshaw H and Friedmann PS (2005) Pioglitazone: a promising therapy for psoriasis. Br J Dermatol 152: 189\u2013191.","DOI":"10.1111\/j.1365-2133.2005.06369.x"},{"key":"10.1124\/jpet.105.091066_bib30","doi-asserted-by":"crossref","unstructured":"Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C, et al. (1998) Differentiation and reversal of malignant changes in colon cancer through PPAR\u03b3. Nat Med 4: 1046\u20131052.","DOI":"10.1038\/2030"},{"key":"10.1124\/jpet.105.091066_bib31","doi-asserted-by":"crossref","unstructured":"Schaefer KL, Denevich S, Ma C, Cooley SR, Nakajima A, Wada K, Schlezinger J, Sherr D, and Saubermann LJ (2005) Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms. Inflamm Bowel Dis 11: 244\u2013252.","DOI":"10.1097\/01.MIB.0000160770.94199.9b"},{"key":"10.1124\/jpet.105.091066_bib32","doi-asserted-by":"crossref","unstructured":"Shafiq N, Malhotra S, Pandhi P, Gupta M, Kumar B, and Sandhu K (2005) Pilot trial: pioglitazone versus placebo in patients with plaque psoriasis (the P6). Int J Dermatol 44: 328\u2013333.","DOI":"10.1111\/j.1365-4632.2005.02504.x"},{"key":"10.1124\/jpet.105.091066_bib33","doi-asserted-by":"crossref","unstructured":"Valdimarsson H, Baker BS, Jonsdottir I, Powles A, and Fry L (1995) Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16: 145\u2013149.","DOI":"10.1016\/0167-5699(95)80132-4"},{"key":"10.1124\/jpet.105.091066_bib34","unstructured":"Varani J, Fligiel SE, Till GO, Kunkel RG, Ryan US, and Ward PA (1985) Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical. Lab Investig 53: 656\u2013663."},{"key":"10.1124\/jpet.105.091066_bib35","doi-asserted-by":"crossref","unstructured":"Varani J, Perone P, Griffiths CE, Inman DR, Fligiel SE, and Voorhees JJ (1994) All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Investig 94: 1747\u20131756.","DOI":"10.1172\/JCI117522"},{"key":"10.1124\/jpet.105.091066_bib36","doi-asserted-by":"crossref","unstructured":"Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, Wang ZQ, Datta SC, Fisher GJ, and Voorhees JJ (2000) Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Investig Dermatol 114: 480\u2013486.","DOI":"10.1046\/j.1523-1747.2000.00902.x"},{"key":"10.1124\/jpet.105.091066_bib37","doi-asserted-by":"crossref","unstructured":"Venkatraman MS, Chittiboyina A, Meingassner J, Ho CI, Varani J, Ellis CN, Avery MA, Pershadsingh HA, Kurtz TW, and Benson SC (2004) \u03b1-Lipoic acid-based PPAR\u03b3 agonists for treating inflammatory skin diseases. Arch Dermatol Res 296: 97\u2013104.","DOI":"10.1007\/s00403-004-0480-5"},{"key":"10.1124\/jpet.105.091066_bib38","doi-asserted-by":"crossref","unstructured":"Wrone-Smith T and Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Investig 98: 1878\u20131887.","DOI":"10.1172\/JCI118989"},{"key":"10.1124\/jpet.105.091066_bib39","doi-asserted-by":"crossref","unstructured":"Zeigler M, Chi Y, Tumas DB, Bodary S, Tang H, and Varani J (2001) Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate. Lab Investig 81: 1253\u20131261.","DOI":"10.1038\/labinvest.3780339"},{"key":"10.1124\/jpet.105.091066_bib40","doi-asserted-by":"crossref","unstructured":"Zeigler ME, Chi Y, Schmidt T, and Varani J (1999) Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 180: 271\u2013284.","DOI":"10.1002\/(SICI)1097-4652(199908)180:2<271::AID-JCP15>3.0.CO;2-D"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524323407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524323407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.091066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:39:30Z","timestamp":1740001170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524323407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0022356524323407"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.091066","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BP-1107 [{2-[4-(2,4-Dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: A Novel Synthetic Thiazolidinedione That Inhibits Epidermal Hyperplasia in Psoriatic Skin-Severe-Combined Immunodeficient Mouse Transplants after Topical Application","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.091066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}